triazoles has been researched along with Benign Cerebellar Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, G; Challagundla, KB; Chaturvedi, NK; Coulter, DW; Joshi, SS; Kesherwani, V; Kling, MJ; McIntyre, EM; Mishra, NK; Ray, S | 1 |
| Band, H; Chaturvedi, NK; Coulter, DW; Griggs, CN; Joshi, SS; Kesherwani, V; Kling, MJ; Liu, Y; McGuire, TR; McIntyre, EM; Ray, S; Sharp, JG; Shukla, M | 1 |
| Bolin, S; Borgenvik, A; Bradner, JE; Cho, YJ; Persson, CU; Qi, J; Sundström, A; Swartling, FJ; Weishaupt, H; Weiss, WA | 1 |
| Balboni Iniguez, A; Bandopadhayay, P; Beroukhim, R; Bradner, JE; Brenan, L; Buchan, G; Carr, SA; Cowley, GS; Coxon, M; Coy, S; Creech, A; Dharia, NV; Dubois, F; Gionet, G; Girard, E; Gokhale, PC; Gonzalez, EM; Goodale, A; Greenwald, NF; Hahn, WC; Ho, P; Hong, AL; Jaffe, JD; Johannessen, CM; Khadka, P; Kieran, MW; Lam, FC; Lee, Y; Ligon, KL; Lin, JR; Meng, A; Milde, T; O'Rourke, R; Olson, JM; Pages, M; Paolella, BR; Pfister, SM; Piccioni, F; Qi, J; Qian, K; Rashid, R; Rees, MG; Root, DE; Roti, G; Santagata, S; Schenone, M; Schoolcraft, K; Shapira, O; Sinai, C; Stegmaier, K; Tanenbaum, B; Tiv, HL; Tracy, A; Tsherniak, A; Vazquez, F; Yaffe, MB | 1 |
| Akture, E; Baskaya, MK; Salamat, S | 1 |
| Althoff, K; Beckers, A; Eggert, A; El-Hindy, N; Fleischhack, G; Henssen, A; Heukamp, L; Odersky, A; Schäfers, S; Schramm, A; Schulte, JH; Speleman, F; Sure, U; Thor, T | 1 |
| Alimova, I; Amani, V; Balakrishnan, I; Birks, DK; Cristiano, B; Foreman, NK; Griesinger, A; Handler, M; Harris, P; Remke, M; Taylor, MD; Venkataraman, S; Vibhakar, R | 1 |
| Alfonsi, R; Brunetti, M; Colaceci, F; Di Marcotullio, L; Filocamo, G; Lahm, A; Mancuso, M; Pasquali, E; Pazzaglia, S; Saran, A; Sasso, R; Steinkühler, C; Tanori, M | 1 |
8 other study(ies) available for triazoles and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
Topics: Animals; Apoptosis; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Epigenesis, Genetic; Histone Deacetylases; Humans; Medulloblastoma; Mice; Nuclear Proteins; Panobinostat; Proto-Oncogene Proteins c-myc; Transcription Factors; Triazoles | 2022 |
A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azepines; Cell Cycle; Cell Proliferation; Cerebellar Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Medulloblastoma; Mice; Mice, Inbred NOD; Mice, SCID; Protein Biosynthesis; Proto-Oncogene Proteins c-myc; Quinolines; TOR Serine-Threonine Kinases; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
Topics: Azepines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Cyclin-Dependent Kinase 2; Drug Synergism; Female; Humans; Medulloblastoma; Piperazines; Protein Kinase Inhibitors; Protein Stability; Proto-Oncogene Proteins c-myc; Pyrazoles; Pyridines; Quinazolines; Sequence Analysis, RNA; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays | 2018 |
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma.
Topics: Animals; Azepines; Basic Helix-Loop-Helix Transcription Factors; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Lineage; Cerebellar Neoplasms; CRISPR-Cas Systems; Cyclin D2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Medulloblastoma; Mice; Neural Stem Cells; Neurogenesis; Proteins; Proto-Oncogene Proteins c-myc; S Phase; Triazoles | 2019 |
Intracranial blastomycosis presenting as an enhancing cerebellopontine mass.
Topics: Adult; Antifungal Agents; Blastomyces; Blastomycosis; Cerebellar Diseases; Cerebellar Neoplasms; Cerebellopontine Angle; Craniotomy; Humans; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Necrosis; Positron-Emission Tomography; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.
Topics: Animals; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cerebellar Neoplasms; Down-Regulation; Female; Gene Knockdown Techniques; Genes, myc; Humans; Medulloblastoma; Mice; Mice, Nude; Nuclear Proteins; Random Allocation; Signal Transduction; Transcription Factors; Transfection; Triazoles; Xenograft Model Antitumor Assays | 2013 |
Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.
Topics: Animals; Apoptosis; Azepines; Biomarkers, Tumor; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cerebellar Neoplasms; Child; Gene Expression Profiling; Humans; Medulloblastoma; Mice; Mice, Nude; Neoplastic Stem Cells; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Prognosis; Proto-Oncogene Proteins c-myc; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Transcription Factors; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Cycle; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Hedgehog Proteins; Humans; Isoxazoles; Medulloblastoma; Mice; Neoplasm Transplantation; Random Allocation; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays | 2016 |